Wird geladen...

Molecular landscape of pancreatic cancer: implications for current clinical trials

Despite recent improvements, overall survival for advanced adenocarcinoma of the pancreas continues to be poor. In comparison to other tumor types that have enjoyed marked survival benefit by targeting aberrant cell signaling pathways, standard of care treatment for pancreatic cancer is limited to c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Heestand, Gregory M., Kurzrock, Razelle
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2015
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4467098/
https://ncbi.nlm.nih.gov/pubmed/25714017
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!